Pressor effect of beta blocking agents in rats.
D000083:Acetanilides / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004347:Drug Interactions; D004837:Epinephrine / Q000494:pharmacology; D005730:Ganglionic Blockers / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D007668:Kidney / Q000502:physiology; D008297:Male; D009392:Nephrectomy; D009638:Norepinephrine / Q000494:pharmacology; D010096:Oxprenolol / Q000494:pharmacology; D010425:Pentolinium Tartrate / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D005730:Ganglionic Blockers; D011437:Propylamines; D013565:Sympatholytics; D010643:Phenoxybenzamine; D000804:Angiotensin II; D010096:Oxprenolol; D010425:Pentolinium Tartrate; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine